SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMC NEWS

TMCNET eNEWSLETTER SIGNUP

U.S. Patents Awarded to Inventors in Illinois (April 13)
[April 13, 2012]

U.S. Patents Awarded to Inventors in Illinois (April 13)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., April 13 -- The following federal patents were awarded to inventors in Illinois.

*** Equistar Chemicals Assigned Patent ALEXANDRIA, Va., April 13 -- Equistar Chemicals, Houston, has been assigned a patent (8,153,544) developed by eight co-inventors for a "method for preparing non-metallocene catalysts." The co-inventors are Sandor Nagy, Naperville, Ill., Linda N. Winslow, Cincinnati, Shahram Mihan, Bad Soden, Germany, Reynald Chevalier, Frankfurt, Germany, Lenka Lukesova, Frankfurt, Germany, Ilya E. Nifant'ev, Moscow, Pavel V. Ivchenko, Moscow, and Karen L. Neal-Hawkins, Cincinnati.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method of preparing supported catalysts useful for olefin polymerization is described. The catalysts comprise a Group 4 metal complex that incorporates a tridentate dianionic ligand. An activator mixture is first made from a boron compound having Lewis acidity and an excess of an alumoxane. The activator mixture is then combined with a support and the Group 4 metal complex to give a supported catalyst. The method provides an active, supported catalyst capable of making high-molecular-weight polyolefins." The patent application was filed on July 22, 2009 (12/460,640). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,153,544.PN.&OS=PN/8,153,544&RS=PN/8,153,544 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Ineos USA Assigned Patent ALEXANDRIA, Va., April 13 -- Ineos USA, Lisle, Ill., has been assigned a patent (8,153,546) developed by four co-inventors for "mixed metal oxide ammoxidation catalysts." The co-inventors are James F. Brazdil, Glen Ellyn, Ill., Mark A. Toft, Somonauk, Ill., Michael J. Seely, Plainfield, Ill., Charles J. Besecker, Batavia, Ill., and Robert A. Gustaferro, Naperville, Ill.


The abstract of the patent published by the U.S. Patent and Trademark Office states: "A catalytic composition useful for the conversion of an olefin selected from the group consisting of propylene, isobutylene or mixtures thereof, to acrylonitrile, methacrylonitrile, and mixtures thereof. The catalytic composition comprising a complex of metal oxides comprising bismuth, molybdenum, iron, cerium and other promoter elements, wherein the X-ray diffraction pattern of the catalytic composition has X-ray diffraction peaks at 2.theta. angle 28.+-.0.3 degrees and 2.theta. angle 26.5.+-.0.3 degrees, and wherein the ratio of the intensity of the most intense x-ray diffraction peak within 2.theta. angle 28.+-.0.3 degrees to the intensity of most intense x-ray diffraction peak within 2.theta. angle 26.5.+-.0.3 degrees is defined as X/Y, and wherein X/Y is greater than or equal to 0.7." The patent application was filed on March 23, 2010 (12/661,705). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,153,546.PN.&OS=PN/8,153,546&RS=PN/8,153,546 Written by Shabnam Sheikh; edited by Jaya Anand.

*** Endotronix Assigned Patent ALEXANDRIA, Va., April 13 -- Endotronix, Peoria, Ill., has been assigned a patent (8,154,389) developed by Harry D. Rowland, East Peoria, Ill., Roger Dwight Watkins, Dunlap, Ill., and Balamurugan Sundaram, Peoria, Ill., for a wireless sensor reader.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A wireless sensor reader is provided to interface with a wireless sensor. The wireless sensor reader transmits an excitation pulse to cause the wireless sensor to generate a ring signal. The wireless sensor reader receives and amplifies the ring signal and sends the signal to a phase-locked loop. A voltage-controlled oscillator in the phase-locked loop locks onto the ring signal frequency and generates a count signal at a frequency related to the ring signal frequency. The voltage-controlled oscillator is placed into a hold mode where the control voltage is maintained constant to allow the count signal frequency to be determined." The patent application was filed on April 7, 2009 (12/419,326). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,154,389&OS=8,154,389&RS=8,154,389 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Motorola Solutions Assigned Patent ALEXANDRIA, Va., April 13 -- Motorola Solutions, Schaumburg, Ill., has been assigned a patent (8,154,329) developed by Lawrence M. Ecklund, Wheaton, Ill., and Robert E. Stengel, Pompano Beach, Fla., for a "device and method for phase compensation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A frequency generation unit is provided that permits a receiver to tune from channel to channel without cycle skipping and in which compensation for phase offset introduced during tuning is provided. The frequency generation unit includes a fractional-N synthesizer, a voltage controlled oscillator (VCO), and a direct digital synthesizer (DDS). The fractional-N synthesizer generates frequencies from the VCO as well as a temperature controlled crystal oscillator. Outputs from the fractional-N synthesizer are supplied both the VCO and the DDS to control the VCO and DDS. The combination of the voltage controlled oscillator and fractional-N synthesizer is perpetually locked. The fractional-N synthesizer is maintained in a locked condition. The VCO output is provided to the DDS. An output from the DDS or from the fractional-N synthesizer forms the output signal of the frequency generation unit." The patent application was filed on Dec. 31, 2009 (12/650,649). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,154,329&OS=8,154,329&RS=8,154,329 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Hamilton Sundstrand Assigned Patent ALEXANDRIA, Va., April 13 -- Hamilton Sundstrand, Rockford, Ill., has been assigned a patent (8,154,372) developed by five co-inventors for a light-weight, conduction-cooled inductor. The co-inventors are Frank Z. Feng, Loves Park, Ill., Steven Schwitters, Rockford, Ill., Clifford G. Thiel, Lanark, Ill., Debabrata Pal, Hoffman Estates, Ill., and John Horowy, Rockford, Ill.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A lightweight inductor for the motor controller of an aircraft starter includes a toroidal inductor core divided into multiple sections that are separated by a thermally conductive, but electrically insulating, material. The inductor core is wound with wire and positioned inside of an electrically and thermally conductive container, which acts as a heat sink and EMI shield, while also reducing eddy currents within the inductor core." The patent application was filed on Dec. 6, 2007 (11/999,614). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,154,372&OS=8,154,372&RS=8,154,372 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** ProactiCare Assigned Patent ALEXANDRIA, Va., April 13 -- ProactiCare, Hinsdale, Ill., has been assigned a patent (8,154,413) developed by Barton Dring, River Forest, Ill., and John Ross, Elmhurst, Ill., for "system and methods for monitoring caregiver performance." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Systems and methods for monitoring the performance of a caregiver are disclosed. The systems may be configured to monitor the movement of each subject in a network of subjects. One such system includes a plurality of strips adhered in spaced-apart relation on a mattress pad, upon which a subject is positioned. One or more transmitter is provided coupled to the plurality of strips. A processor is connected to the one or more transmitter. The processor is provided with operating software to record and report caregiver activity or both caregiver activity and subject activity." The patent application was filed on June 1, 2009 (12/455,347). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,154,413&OS=8,154,413&RS=8,154,413 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** NorthShore University HealthSystem Assigned Patent ALEXANDRIA, Va., April 13 -- NorthShore University HealthSystem, Evanston, Ill., has been assigned a patent (8,154,287) developed by Robert R. Edelman, Highland Park, Ill., and Ioannis Koktzoglou, Rolling Meadows, Ill., for a "system and method for ghost magnetic resonance imaging." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system and method enables the creation of medical images using data related to ghost artifacts. The method thus allows components of an imaged subject to be segmented based on state changes in the components that lead to the controlled production of ghost artifacts. This is achieved in MR by performed a pulse sequence so that multiple sets of MR data are acquired in which the signals from a target tissue vary across the data sets while the signals from a background tissue do not vary across the data sets. A composite data set is generated by populating selected k-space lines of the composite data set with information from a first MR data set and populating the remaining k-space lines of the composite data set with information from a second MR data set. An MR image is then reconstructed from the composite data set. The MR image contains ghost artifacts that faithfully reproduce the 2D or 3D anatomic detail of the target tissues without signal contributions from the background tissues, allowing for background-suppressed or segmented MR images of a target tissue without the need for image subtraction." The patent application was filed on July 24, 2009 (12/509,180). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,154,287&OS=8,154,287&RS=8,154,287 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Archer Daniels Midland Assigned Patent ALEXANDRIA, Va., April 13 -- Archer Daniels Midland, Decatur, Ill., has been assigned a patent (8,153,847) developed by Paul Bloom, Decatur, Ill., for a "hydrogenolysis of glycerol and products produced therefrom." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process is provided for producing biobased propylene glycol, the process comprising placing a biobased glycerol containing solution at a concentration of at least 20% glycerol by weight and hydrogen in contact with a solid catalyst such that the biobased propylene glycol is formed." The patent application was filed on May 30, 2008 (12/130,124). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,847&OS=8,153,847&RS=8,153,847 Written by Arpi Sharma; edited by Anand Kumar.

*** University of Washington, Novartis Vaccines and Diagnostics Assigned Patent ALEXANDRIA, Va., April 13 -- The University of Washington, Seattle, and Novartis Vaccines and Diagnostics, Emeryville, Calif., have been assigned a patent (8,153,843) developed by eleven co-inventors for antibacterial agents. The co-inventors are Niels H. Andersen, Seattle, Jason Bowman, Quincy, Ill., Alice L. Erwin, Seattle, Eric A. Harwood, Seattle, Toni Kline, Seattle, Khisimuzi E. Mdluli, New York, Simon Ng, Emeryville, Calif., Keith B. Pfister, Emeryville, Calif., Ribhi Shawar, Phoenixville, Pa., Allan S. Wagman, Belmont, Calif., and Asha Yabannavar, Emeryville, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Antibacterial compounds of formula I are provided: ##STR00001## As well as stereoisomers, pharmaceutically acceptable salts, esters, and prodrugs thereof; pharmaceutical compositions comprising such compounds; methods of treating bacterial infections by the administration of such compounds; and processes for the preparation of the compounds." The patent application was filed on Sept. 21, 2009 (12/563,697). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,843&OS=8,153,843&RS=8,153,843 Written by Arpi Sharma; edited by Anand Kumar.

*** Abbott Laboratories Assigned Patent ALEXANDRIA, Va., April 13 -- Abbott Laboratories, Abbott Park, Ill., has been assigned a patent (8,153,813) developed by eight co-inventors for a "benzothiazole and benzooxazole derivatives and methods of use." The co-inventors are Lawrence A. Black, Libertyville, Ill., Marlon D. Cowart, Round Lake Beach, Ill., Gregory A. Gfesser, Lindenhurst, Ill., Brian D. Wakefield, Vernon Hills, Ill., Robert J. Altenbach, Chicago, Huaqing Liu, Buffalo Grove, Ill., Chen Zhao, Libertyville, Ill., and Gin C. Hsieh, Long Grove, Ill.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Compounds of formula (I) ##STR00001## are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds." The patent application was filed on Dec. 17, 2008 (12/337,433). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,813&OS=8,153,813&RS=8,153,813 Written by Arpi Sharma; edited by Anand Kumar.

*** Colorado State University Research Foundation, Brigham Young University Technology Transfer Office, Children's Hospital Medical Center of Cincinnati Assigned Patent ALEXANDRIA, Va., April 13 -- Colorado State University Research Foundation, Fort Collins, Colo., Brigham Young University Technology Transfer Office, Provo, Utah, and Children's Hospital Medical Center of Cincinnati, Cincinnati, have been assigned a patent (8,153,684) developed by four co-inventors for "use of equol for treating androgen mediated diseases." The co-inventors are Edwin Douglas Lephart, Orem, Utah, Trent D. Lund, Wheaton, Ill., Kenneth David Reginald Setchell, Cincinnati, and Robert J. Handa, Fort Collins, Colo.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Equol (7-hydroxy-3(4'hydroxyphenyl)-chroman), the major metabolite of the phytoestrogen daidzein, specifically binds and blocks the hormonal action of 5.alpha.-dihydrotestosterone (DHT) in vitro and in vivo. Equol can bind circulating free DHT and sequester it from the androgen receptor, thus altering growth and physiological hormone responses that are regulated by androgens. These data suggest a novel model to explain equol's biological properties. The significance of equol's ability to specifically bind and sequester DHT from the androgen receptor have important ramifications in health and disease and may indicate a broad and important usage for equol in the treatment and prevention of androgen-mediated pathologies. Thus, equol can specifically bind DHT and prevent DHT's biological actions in physiological and pathophysiological processes." The patent application was filed on Oct. 2, 2009 (12/572,791). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,684&OS=8,153,684&RS=8,153,684 Written by Arpi Sharma; edited by Anand Kumar.

*** Polyone, Amcol International Assigned Patent ALEXANDRIA, Va., April 13 -- Polyone, Avon Lake, Ohio, and Amcol International, Arlington Heights, Ill., have been assigned a patent (8,153,710) developed by David A. Jarus, Avon Lake, Ohio, and Guoqiang Qian, Arlington Heights, Ill., for a "weatherable polyolefin nanocomposites." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method is disclosed concerning discovering how the use of an additive in a polyolefin compound affects the weatherability of that compound, Applying that technique, a weatherable polyolefin nanocomposite is disclosed, which contains UV stabilizers that filter wavelengths in a range influenced by presence of organoclay in the nanocomposite." The patent application was filed on March 28, 2011 (13/073,565). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,710&OS=8,153,710&RS=8,153,710 Written by Arpi Sharma; edited by Anand Kumar.

*** Georgetown University Assigned Patent ALEXANDRIA, Va., April 13 -- Georgetown University, Washington, has been assigned a patent (8,153,657) developed by Alan P. Kozikowski, Chicago, and Jia Zhou, Washington, for a "dopamine-, norepinephrine- and serotonin-transporter-selective heterocyclic compounds and their therapeutic applications." The abstract of the patent published by the U.S. Patent and Trademark Office states: "One aspect of the invention relates to piperidine compounds that are useful as inhibitors of monoamine transporters. The invention also relates to pharmaceutical compositions, comprising a piperidine compound of the invention. Another aspect of the present invention relates to the use of the aforementioned compounds in a method of treating a disorder of the central nervous system in a mammal." The patent application was filed on Oct. 22, 2004 (10/576,620). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,153,657&OS=8,153,657&RS=8,153,657 Written by Arpi Sharma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1082160 (c) 2012 Targeted News Service

[ Back To TMCnet.com's Homepage ]





LATEST VIDEOS

DOWNLOAD CENTER

UPCOMING WEBINARS

MOST POPULAR STORIES





Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2013 Technology Marketing Corporation. All rights reserved.